Skip to content

Author

Dirk Koschel

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Increased number of chemotherapy cycles during radiochemotherapy improves overall survival without increasing toxicity in locally advanced non-small cell lung cancer patients.

PURPOSE Radiochemotherapy (RCHT) followed by immunotherapy is the standard of care for unresectable, locally advanced non-small cell lung cancer (LA-NSCLC) patients. However, the impact of chemotherapy cycles and consolidation durvalumab on overall survival and toxicity remains uncertain in a real-life cohort. METHOD...

A. Simbirova, Steffen Loeck, S. Appold et al. · 0 citations
Open access Sep 2026

Progression-survival dissociation in connective tissue disease (CTD)-associated interstitial lung disease (ILD): CTD-ILD versus non-CTD ILD in real-world practice

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a clinically relevant subtype of fibrotic ILD. We compared baseline characteristics, treatment patterns, transplant-free survival (TFS) and progression-free survival (PFS) between CTD-ILD and non-CTD ILD. In the prospective German IN...

J. Behr, F. Bonella, Andreas Günther et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.